Catalyst Pharmaceuticals Inc (CPRX) – Company Profile and SWOT Analysis
- Pages: 53
- Published: May 2026
- Report Code: MLPH62488FSA
Catalyst Pharmaceuticals Inc (CPRX) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Key Highlights
Catalyst Pharmaceuticals Inc (Catalyst) is a commercial-stage biopharmaceutical company. It focuses on in-licensing, developing and commercializing prescription drugs that target rare neurological and neuromuscular diseases. The company’s product portfolio includes Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in children and adults, Fycompa (perampanel) tablets and oral suspension, for the treatment of partial-onset seizures, and Agamree (vamorolone) oral suspension, a corticosteroid with a novel structure for the treatment of Duchenne Muscular Dystrophy (DMD). Catalyst sells its products through a field force and specialty pharmacies for distribution. The company operates in the US and through its subsidiary, in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.
Scope
• Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis
• An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments
• News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
BioMarin Pharmaceutical Inc
ANI Pharmaceuticals Inc
Sarepta Therapeutics Inc
PTC Therapeutics Inc
Xeris Biopharma Holdings Inc
Jacobus Pharmaceutical Co Inc
Marinus Pharmaceuticals Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.